Home›Companies›Biotech & Pharma›BlueWhale Bio

BlueWhale Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 16, 2025·Suggest an edit

About BlueWhale Bio

BlueWhale Bio is a private company based in Philadelphia, Pennsylvania, incorporated in 2022 in Delaware. It has reported $5,000,000 raised in one offering on Form D since October 2025. Its chief executive is Peter Keller.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 10, 2025Oct 16, 2025$5,000,000of $15.0M target1$5.0MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on BlueWhale Bio's Form D filed Oct 16, 2025.

EH
Elaine Heron
Director
PK
Peter Keller
Chief Executive Officer and director
PM
Paul Meister
Director
PC
Paula Cannon
Director

Sources

  1. SECBlueWhale Bio, Inc. filing history